Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across …

J Alderfer, JMJ Alvir, JP Cook, K Gilchrist… - Current Medical …, 2022 - Taylor & Francis
Objectives To assess patient characteristics, treatment patterns, and patient-reported
outcomes (PROs) associated with authorized generics (AGs) and independent generics …

Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use

JP Brito, JS Ross, Y Deng, L Sangaralingham… - Endocrine, 2021 - Springer
Purpose To compare cardiovascular outcomes and rates of fractures and falls among
patients with persistent brand-name versus generic L-thyroxine use. Methods Retrospective …

Real world evidence in effectiveness, safety, and cost savings of generic levothyroxine: a systematic review

J Qian, KA Tanni - Endocrine, 2021 - Springer
Purpose Generic levothyroxine, approved through Abbreviated New Drug Application
(ANDA), is available for generic substitution. But ANDA does not require nonclinical or …